Abstract:Concerning the emergence of resistance to current anti-influenza drugs, our previous phenotypic-based screening study identified the compound A9 as a promising lead compound. This chalcone analog, containing a 2,6-dimethoxyphenyl moiety, exhibited significant inhibitory activity against oseltamivir-resistant strains (H1N1 pdm09), with an EC 50 value of 1.34 μM. However, it also displayed notable cytotoxicity, with a CC 50 value of 41.46 μM. Therefore, compound A9 was selected as a prototype structure for further structural optimization in this study. Initially, it was confirmed that the substituting the α,β -unsaturated ketone with pent-1,4-diene-3-one as a linker group significantly reduced the cytotoxicity of the final compounds. Subsequently, the penta-1,4-dien-3-one group was utilized as a privileged fragment for further structural optimization. Following two subsequent rounds of optimizations, we identified compound IIB-2 , which contains a 2,6-dimethoxyphenyl- and 1,4-pentadiene-3-one moieties. This compound exhibited inhibitory effects on oseltamivir-resistant strains comparable to its precursor (compound A9 ), while demonstrating reduced toxicity (CC 50 > 100 μM). Furthermore, we investigated its mechanism of action against anti-influenza virus through immunofluorescence, Western blot , and surface plasmon resonance (SPR) experiments. The results revealed that compound IIB-2 can impede virus proliferation by blocking the export of influenza virus nucleoprotein. Thusly, our findings further emphasize influenza nuclear export as a viable target for designing novel chalcone-like derivatives with potential inhibitory properties that could be explored in future lead optimization studies.

Discovery of Iminosugar Derivatives with Strong IFN‐γ Inducing Activity

Design and Syntheses of Some Iminosugar Derivatives As Potential Immunosuppressants

Synthetic Iminosugar Derivatives As New Potential Immunosuppressive Agents

N-Arylated-Lactam-Type Iminosugars As New Immunosuppressive Agents: Discovery, Optimization, and Biological Evaluation

Discovery of Novel Thieno[2,3-d]imidazole Derivatives As Agonists of Human STING for Antitumor Immunotherapy Using Systemic Administration.

Rapid synthesis of iminosugar derivatives for cell-based in situ screening: Discovery of "hit" compounds with anticancer activity

Synthesis of N-Dialkylphosphoryl Iminosugar Derivatives and Their Immunosuppressive Activities

Synthetic N-alkylated iminosugars as new potential immunosuppressive agents.

Synthesis of N‐Substituted Iminosugar Derivatives and Evaluation of Their Immunosuppressive Activities

ChemInform Abstract: Iminosugars As Immunomodulating Agents: Synthesis and Biological Activities of 1‐deoxynojirimycin and Related Compounds

Iminosugars As Immunomodulating Agents: Synthesis And Biological Activities Of 1-Deoxynojirimycin And Related Compounds

Synthesis of N-substituted iminosugar derivatives and their immunosuppressive activities

Synthesis and Biological Evaluation of N-Arylated-Lactam-Type Iminosugars As Potential Immunosuppressive Agents

Structure−Activity Relationship Study of Benzothiophene Oxobutanoic Acid Analogues Leading to Novel Stimulator of Interferon Gene (STING) Agonists

Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists

Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

An expeditious one-pot synthesis of 1,6-dideoxy-N-alkylated nojirimycin derivatives and their inhibitory effects on the secretion of IFN-γ and IL-4

Design, synthesis, and evaluation of thiazolecarboxamide derivatives as stimulator of interferon gene inhibitors

Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors

Discovery of imidazoleisoindole derivatives as potent IDO1 inhibitors: Design, synthesis, biological evaluation and computational studies.

Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses